Sublingual microcirculation is impaired on the first day postoperatively in patients undergoing gastric tube reconstruction

por Van Bommel, J, Tilanus, H, Bakker, J, Gommers, D
Publicado 2007

The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis

por Koppert, L B, Schutte, M, Abbou, M, Tilanus, H W, Dinjens, W N M
Publicado 2004

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer

por Gaast, A van der, Kok, T C, Kerkhofs, L, Siersema, P D, Tilanus, H W, Splinter, T A W
Publicado 1999

E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus

por Wijnhoven, B P L, Both, N J de, Dekken, H van, Tilanus, H W, Dinjens, W N M
Publicado 1999

Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116

por Wijnhoven, B P L, Tilanus, M G J, Morris, A G, Darnton, S J, Tilanus, H W, Dinjens, W N M
Publicado 2000

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

por Kok, T. C., Van der Gaast, A., Dees, J., Eykenboom, W. M., Van Overhagen, H., Stoter, G., Tilanus, H. W., Splinter, T. A.
Publicado 1996

Does Routine Endoscopy or Contrast Swallow Study After Esophagectomy and Gastric Tube Reconstruction Change Patient Management?

por Nederlof, N., de Jonge, J., de Vringer, T., Tran, T. C. K., Spaander, M. C. W., Tilanus, H. W., Wijnhoven, B. P. L.
Publicado 2016

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer

por Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., van Lanschot, J. J. B.
Publicado 2010

Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.

por Hinnen, P., de Rooij, F. W., van Velthuysen, M. L., Edixhoven, A., van Hillegersberg, R., Tilanus, H. W., Wilson, J. H., Siersema, P. D.
Publicado 1998

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands

por van Vliet, E P M, Eijkemans, M J C, Steyerberg, E W, Kuipers, E J, Tilanus, H W, van der Gaast, A, Siersema, P D
Publicado 2006

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

por van Meerten, E, Muller, K, Tilanus, H W, Siersema, P D, Eijkenboom, W M H, van Dekken, H, Tran, T C K, van der Gaast, A
Publicado 2006

Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus

por Boogert, J van den, Hillegersberg, R van, Staveren, H J van, Bruin, R W F de, Dekken, H van, Siersema, P D, Tilanus, H W
Publicado 1999

Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid

por Hinnen, P, Rooij, F W M de, Terlouw, E M, Edixhoven, A, Dekken, H van, Hillegersberg, R van, Tilanus, H W, Wilson, J H P, Siersema, P D
Publicado 2000

Centralization of Esophageal Cancer Surgery: Does It Improve Clinical Outcome?

por Wouters, M. W. J. M., Karim-Kos, H. E., le Cessie, S., Wijnhoven, B. P. L., Stassen, L. P. S., Steup, W. H., Tilanus, H. W., Tollenaar, R. A. E. M.
Publicado 2009

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

por Polee, M B, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Verweij, J, Stoter, G, van der Gaast, A
Publicado 2002

Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial

por Verschuur, E M L, Steyerberg, E W, Tilanus, H W, Polinder, S, Essink-Bot, M-L, Tran, K T C, van der Gaast, A, Stassen, L P S, Kuipers, E J, Siersema, P D
Publicado 2009

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression

por Koppert, L B, van der Velden, A W, van de Wetering, M, Abbou, M, van den Ouweland, A M W, Tilanus, H W, Wijnhoven, B P L, Dinjens, W N M
Publicado 2004

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

por Polee, M B, Hop, W C J, Kok, T C, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Stoter, G, van der Gaast, A
Publicado 2003